Abstract. We investigated the effects of brefeldin A and ilimaquinone, inhibitors of membrane trafficking, using serotonin transporter (SERT)-expressing COS-7 cells. Both drugs significantly inhibited the serotonin uptake activity of SERT and caused SERT to be retained in the endoplasmic reticulum (ER), indicating that membrane trafficking is an important factor for SERT functional regulation. In agreement with previous reports, a C-terminal-deletion mutant of SERT (SERTΔCT) mostly localized to the ER and completely lacked serotonin uptake activity. To further elucidate the role of the C-terminus of SERT, we investigated whether overexpression of FLAG-tagged SERT C-terminus (FLAG-SERT-CT) affected the serotonin uptake activity and glycosylation of SERT. Interestingly, when concomitantly expressed with full-length FLAG-SERT in COS-7 cells, FLAG-SERT-CT increased the serotonin uptake activity and mature glycosylation of FLAG-SERT. These results indicate that the C-terminal region of SERT plays a crucial role in the functional regulation of SERT via membrane trafficking and glycosylation. In addition, proteasome inhibitors induced apparent ER stress, significantly decreased the serotonin uptake activity and mature glycosylation of SERT and caused SERT to be localized to the ER, suggesting that SERT function would be attenuated via membrane trafficking in pathological states that trigger ER stress.
Introduction
Serotonin is a neurotransmitter involved in the regulation of various neural functions, including emotion, sleep, feeding, movement, and temperature control (1) . Among the molecules constituting the serotonergic nervous system, serotonin transporter (SERT) is a membrane protein that plays an important role in terminating serotonergic neural transmission by re-uptaking serotonin into the presynaptic terminal (2) . In contrast to the diversity of serotonin receptors, a single SERT is thought to participate in the clearance of extracellular serotonin in central as well as peripheral tissues (3 -6) . SERT also has crucial roles in the pathogenesis of mood disorders and drug addiction because the molecule is the target of antidepressants and abusive drugs (7 -10) . In addition, SERT is associated with the anxiety trait and with vulnerability to stress, based on studies on polymorphisms in the SERT gene (11, 12) . Recently, missense mutations in the coding region of the SERT gene were identified in families with autism and obsessivecompulsive disorder (13, 14) . Taken together, SERT emerges as a molecule involved in various neuropsychiatric disorders, including autism, drug addiction, mood disorder, anxiety disorder, and other stress-related diseases.
SERT belongs to the SLC6 family of Na + -and Cl − -dependent neurotransmitter transporters, which include other monoamine transporters, the dopamine transporter (DAT) and the norepinephrine transporter (NET) (15) . The structure of SERT consists of 12 transmembrane domains and the amino-and carboxyl-termini are located intracellularly (3, 4) . In the second extracellular loop of SERT, there are two asparagine residues, which are putative sites for glycosylation. Accumulated evidence reveals that proper glycosylation is important for membrane trafficking and functional expression of SERT (16) . SERT protein is synthesized and folded in the endoplasmic reticulum (ER) and is glycosylated with high-mannose-type oligosaccharides. Thereafter, it is trafficked to the Golgi apparatus and undergoes mature-glycosylation there, followed by trafficking to the plasma membrane (17 -19) . Many SERT-binding proteins, including syntaxin 1A (20) , MacMARCKS (21) , , SCAMP2 (23) , nNOS (24) , Rab4 (25) , M6B (26) , α-synuclein (27) , and integrin α IIb β 3 (28) , are thought to regulate SERT function via membrane trafficking and the glycosylation process. The different regulation of membrane trafficking has been pointed out in some of the missense mutants of SERT identified in families susceptible to autism (13, 29) . However, the molecular mechanisms by which these processes are regulated have not been fully elucidated.
The carboxyl-terminus of SERT is a critical region for association with SERT-binding proteins such as α-synuclein (27) and nNOS (24) . This region is also thought to be important for interaction with the actin cytoskeleton (21, 30) . Recently, it was reported that deletion of the C-terminus of SERT abolished its serotonin-uptake activity, suggesting that this region has a critical role in SERT regulation via membrane trafficking and glycosylation (31) . Similar events were observed for the other types of monoamine transporters, NET and DAT (32 -34) , also attesting to the vital roles of the SERT C-terminal domain in its functional regulation.
In addition, in the cases of brain ischemia, neural aging, and neurodegeneration, ER stress is caused by peroxidative stress and accumulated proteins resistant to degradation (35 -37) . Investigations considering how SERT membrane trafficking is affected in the case of ER stress can elucidate the correlation between the physiological significance of SERT regulation via membrane trafficking and the pathology of SERTrelated disease.
In this study, we aim to elucidate the role of the Cterminal region of SERT in its functional regulation with respect to glycosylation and membrane trafficking. Furthermore, we also examine the effects of ER stress inducers on membrane trafficking and functional regulation of SERT.
Materials and Methods

Materials
Glass-bottom culture dishes were purchased from MatTek Corporation (Ashland, MA, USA). Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), and penicillin/streptomycin mixture were purchased from Sigma (St. Louis, MO, USA), Biological Industries (Kibbutz, Israel), and Nacalai Tesque (Kyoto), respectively.
Mouse monoclonal anti-FLAG M2 antibody was purchased from Sigma. Anti-Bip (GRP78) antibody was purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-mouse or rabbit IgG antibodies conjugated with Alexa Fluor fluorescent dyes and ER-tracker TM BlueWhite DPX were purchased from Molecular Probes (Eugene, OR, USA). HRP-conjugated anti-Mouse or anti-Goat IgG was purchased from Jackson ImmunoReseach (West Grove, PA USA). Serotonin (5-hydroxytryptamine) and N-acetyl-Leu-Leu-Nle-CHO (ALLN) were purchased from Sigma. Ilimaquinone (IQ) and brefeldin A (BFA) were purchased from BioMol (Plymouth Meeting, PA, USA). Lactacystin was purchased from Chemicon (Temecula, CA, USA). 
DNA constructs
A plasmid that can express FLAG-tagged rat SERT in mammalian cells was constructed as described before (30) . In brief, a rat SERT cDNA fragment with MunI sites in both the 5' and the 3' ends was obtained by PCR using the full-length rat SERT cDNA as a template. Obtained PCR products were subcloned into an expression plasmid, pTB701FL, which can add FLAG amino acid residues to the N-terminus of the target protein. The plasmid is designated as FL-SERT. To make a plasmid for expressing mutant SERTΔCT, a cDNA fragment encoding a partial SERT gene that lacks the C-terminus (amino acids 1 -600) was obtained by PCR. The PCR product was subcloned into pTB701 FL in the same manner used to make FL-SERT. This plasmid is designated as FLAG-SERTΔCT. To make a plasmid for overexpressing the C-terminus of SERT, a cDNA fragment encoding the C-terminal region of SERT (amino acids 601 -630) was obtained by PCR. The PCR product was subcloned into pTB701FL. This plasmid was designated as FL-SERT-CT. To make plasmids for overexpressing the subregion of SERT C-terminus, two sets of sense and antisense oligoneucleotides corresponding to the amino acids 601 -615 or 613 -630 was firstly synthesized. Each set of oligoneucleotides was annealed and phosphorylated by T4 kinase (NEB, Ipswich, MA, USA) at 37°C for 30 min. Annealed double-strand DNA was separated by agarose gel electrophoresis, and DNAs with appropriate size were subcloned into pTB701FL. These plasmids were designated as FLAG-SERT-CT (601 -615) and FLAG-SERT-CT (613 -630). All PCR products and annealed DNA were verified by sequencing. A plasmid that can express DAT was constructed as described previously (30) . Rat DAT cDNA was subcloned into pTB701FL.
Cell culture and transfection
COS-7 cells were cultured in DMEM supplemented with heat-inactivated FBS (10%), penicillin (100 unit/ml), and streptomycin (100 μg/ ml). Culturing was performed in a humidified atmosphere containing 5% CO 2 at 37°C. A total of 20 μg of plasmid was transfected into 6 × 10 6 COS-7 cells by electroporation using a Gene Pulser (960 mF, 220 V; Bio-Rad, Tokyo). Transfected cells were cultured for 2 days and used for later analysis. H]serotonin uptake in the presence of 10 μM fluvoxamine was also measured and was considered as the non-specific serotonin uptake by the cells. The specific serotonin uptake was obtained by subtracting the non-specific serotonin uptake from the total uptake amount. The serotonin uptake assay was carried out at a concentration of 100 nM serotonin. The [ ]dopamine-uptake assay, the inhibitor used was 100 μM cocaine. In order to calculate the uptake per mg of cell protein, the concentration of protein in the cell extract was measured using a BCA protein assay kit according to the manufacturer's directions (Pierce Biotech., Rockford, IL, USA).
Western blotting
Western blotting was carried out as previously described (39) . In brief, cells (6 × 10 6 ) were harvested and resuspended in homogenate buffer (250 mM sucrose, 2 mM EDTA, 10 mM EGTA, 20 mM Tris-HCl, pH 7.4). Then, the cells were centrifuged at 3000 rpm for 5 min at 4°C, and the pellet was gently resuspended in 100 μl of homogenate buffer containing 1% Triton-X and protease inhibitors (200 μg/ml of leupeptin and 1 mM PMSF). The concentration of protein in cell lysates was measured using a BCA protein assay kit. The 20-to 50-μg protein of cell lysate sample was electrophoretically separated by SDS-PAGE and then transferred onto polyvinylidene difluoride (PVDF) filters (Millipore, MA, USA). After non-specific binding sites on PVDF filters were blocked with 5% non-fat milk for 1 h at room temperature (RT), membranes were incubated with primary antibodies overnight at 4°C. The primary antibodies used in this study were anti-FLAG M2 monoclonal antibody (diluted 1:1000) and anti-Bip (GRP78) polyclonal antibody (1:200). After the primary incubation, filters were incubated with peroxidase-conjugated anti-mouse or anti-goat IgG secondary antibody (1:10000; Jackson ImmunoRes. Lab Inc., West Grove, PA, USA) for 1 h at RT. Immunoreactive bands were visualized with an ECL kit according to the manufacturer's directions (GE Healthcare Japan, Tokyo). Densities of immunoreactive bands were measured using a luminescent image analyzer (LAS1000-plus; Fuji Photo, Tokyo).
Immunocytochemistry and confocal microscopy
Transfected COS-7 cells were cultured in glassbottom dishes (3.5 cm in diameter, MatTek Corp.). Immunocytochemistry was carried out as previously described (30) . In brief, the cells were washed in 1 ml PBS and fixed with 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate-buffered saline (PBS, pH 7.4) for 30 min at RT, washed twice with 1 ml PBS, and then permeabilized with 500 μl PBS supplemented with 0.3% Triton X-100 and 5% normal goat serum (NGS) for 15 min. Next, cells were washed twice with 1 ml PBS with 0.03% Triton-X (PBS-T) and incubated for <1 h at RT with anti-FLAG M2 antibody, followed by incubation for <1 h at RT with a secondary antibody, anti-mouse IgG conjugated with Alexa Fluor 488
(1:500), in PBS-T and 5% NGS. For the double-staining of FLAG-SERT and the ER, cells were initially incubated in culture medium containing ER tracker (1:500) for 1 h at 37°C. Then, the cells were fixed and stained with anti-FLAG as described above.
Fluorescent signals were observed by confocal laser scanning fluorescent microscopy (LSM 510 invert; Carl Zeiss, Jena, Germany). The fluorescence of Alexa Fluor 488 was observed at 488-nm argon excitation using a 510 -525-nm band pass barrier filter. The fluorescence of the ER tracker was observed at 364-nm ultraviolet laser excitation using a 385 -470-nm band pass barrier filter. Multi track mode was used for observing doublestained samples.
Statistical analysis
Data analysis and statistics were carried out using the Prism 4 software (GraphPad Software, San Diego, CA, USA). Statistical significance was determined using Student's t-test. If the P-value was less than 0.05 (P<0.05), the difference was considered statistically significant.
Results
Effects of BFA and IQ, inhibitors of membrane trafficking from ER to the plasma membrane, on SERT function
To elucidate whether membrane trafficking is important for the functional expression of SERT, we investigated the effects of two types of membrane trafficking inhibitors, BFA and IQ, on serotonin uptake activity and localization of SERT. BFA disturbs anterograde protein transport from the ER to the Golgi apparatus by inhibiting transport in the Golgi apparatus, which leads to protein accumulation inside the ER (40, 41) . IQ is a cell-permeable marine sponge metabolite that induces complete and reversible breakdown of Golgi membranes into smaller vesicular structures, thereby preventing protein transport (42) .
COS-7 cells were transfected with 20 μg FLAG-SERT plasmid. The cells were treated with BFA (5 and 10 μg/ml) and IQ (30 μM) for 16 and 2 h before the [ 3 H]serotonin uptake assay, respectively (42 -45) . BFA treatment significantly inhibited SERT activity in a dose-dependent manner. BFA at 5 and 10 μg/ml reduced the [ 3 H]serotonin uptake by approximately 60% and 75%, respectively (Fig 1a) . IQ (30 μM) also significantly inhibited [ 3 H]serotonin uptake activity (Fig. 1a) . We also investigated how BFA and IQ affect the localization of SERT. As shown in Fig. 1b , FLAG-SERT was localized throughout the cell, especially at the plasma membrane. Additionally, punctate structures were seen in the cytoplasm and perikaryon (Fig. 1b, control). Treatment with BFA resulted in FLAG-SERT being retained in dot-like structures in the perikaryon (Fig 1b, BFA) . Also, in IQ-treated cells, FLAG-SERT mostly localized in punctate structures throughout the cytoplasm, and less FLAG-SERT was seen at the plasma membrane compared with the control. (Fig 1b, IQ) . To identify in which organelle FLAG-SERT was being retained in a dot-like manner after BFA or IQ treatment, double-staining with FLAG-SERT and an ER marker was performed. In this study, ER-tracker was used as an ER marker. As shown in Fig. 1c , FLAG-SERT was mainly localized at the plasma membrane and was scarcely colocalized with ER tracker in non-treated control cells. On the other hand, as shown in Fig. 1, d and e, the punctate FLAG-SERT accumulations partially colocalized with the ER when the cells were treated with BFA and IQ, respectively. These results suggest that SERT membrane trafficking is important for its functional regulation.
Characterization of a C-terminus-deletion SERT mutant (FLAG-SERTΔCT)
To elucidate the role of the C-terminus of SERT in its membrane trafficking and glycosylation, we expressed in COS-7 cells a mutant SERT, in which the 30 amino acids of the C-terminal portion were deleted (FLAG-SERTΔCT), and investigated its cellular localization, glycosylation state, and serotonin-uptake activity.
Images obtained by confocal microscopy revealed that FLAG-SERTΔCT mostly localized in vesicular-like or dot-like structures throughout the cytoplasm and perikaryon, not at the plasma membrane (Fig. 2) . In contrast, wild-type FLAG-SERT localized to the plasma membrane as well as in the cytoplasm and perikaryon (Fig. 1a) . FLAG-stained images merged with ER-tracker images showed that the vesicular-like or dot-like SERTlocalized structures were partially colocalized with the ER (Fig. 1c and Fig. 2) .
Next, we investigated how the deletion of the Cterminus of SERT affects its state of glycosylation. Western blotting analysis revealed that the FLAG-SERT protein was recognized as multiple bands with molecular sizes of approximately 60, 80, 120, 160, and 200 kDa. Our previous study (46) clarified that a band with a molecular size of 80 kDa (arrow) corresponds to maturely glycosylated SERT, which should be functionally expressed at the plasma membrane (Fig. 3a) . A band with a molecular size of 60 kDa (arrow head) was SERT, modified by high-mannose-type oligosaccharides. This immaturely glycosylated SERT should be retained in the ER. Our previous study also demonstrated that bands with molecular sizes greater than 80 kDa correspond to dimer, tetramer, and other oligomers of immaturely 3 . Comparison of the glycosylation state and serotonin uptake activity of FLAG-SERT and FLAG-SERTΔCT. a) Immunoblotting of FLAG-SERT expressed in COS-7 cells. FLAG-SERT was recognized as several bands of different molecular size by immunoblotting with anti-FLAG antibody. The arrow indicates the maturely glycosylated FLAG-SERT, which should be expressed at the cell surface. The arrowhead indicates FLAG-SERT with high-mannose-type glycosylation, which should be retained in the ER. b) Immunoblotting of FLAG-SERT and FLAG-SERTΔCT. In contrast to FLAG-SERT, for FLAG-SERTΔCT, the density of the maturely glycosylated form (arrow) was decreased and that of the high-mannose-type SERT was increased (gray arrow heads). c) Marked reduction of the glycosylation index (the ratio of maturely glycosylated FLAG-SERT to high-mannose-type FLAG-SERT) was seen in FLAG-SERTΔCT. d) The serotonin uptake activity was completely abolished in FLAG-SERTΔCT (*P<0.0001 vs. control, Student's t-test). Fig. 4 . Effects of FLAG-SERT-CT overexpression on the function of concomitantly expressed SERT. a) FLAG-SERT and FLAG-SERT-CT were co-transfected into COS-7 cells. Overexpression of FLAG-SERT-CT dose-dependently and significantly increased the serotonin uptake activity of SERT (*P<0.01 vs. control, Student's t-test). b) Overexpression of FLAG-SERT-CT increased maturely glycosylated FLAG-SERT (arrow) when co-expressed with FLAG-SERT in COS-7 cells. c) Overexpression of FLAG-SERT-CT significantly increased the glycosylation index of FLAG-SERT in a dose-dependent manner (*P<0.01 vs. control, Student's t-test). d) FLAG-SERT-CT was immunostained with anti-FLAG antibody. FLAG-SERT-CT partially co-localized with ER tracker staining. Bar indicates 10 μm.
glycosylated SERT (gray arrow heads) (46) . As shown in Fig. 3b , in SERTΔCT-expressing cells, the density of the maturely glycosylated band was robustly reduced (arrow) and, conversely, that of the oligomers of immaturely glycosylated band was increased (gray arrow heads), although the density of monomer was not increased (arrow head). Because 30 amino acids of the C-terminus were deleted in SERTΔCT, the molecular size of SERTΔCT was slightly smaller than that of wild SERT, as expected. To quantify the state of SERT glycosylation, the ratio of 60 kDa-band density (arrow head, immaturely glycosylated SERT) to 80 kDa-band density (arrow, maturely glycosylated SERT) was measured as an index showing the maturely glycosylated state of SERT. As shown in Fig. 3c , the glycosylation index of FLAG-SERTΔCT was robustly reduced compared with the glycosylation index of wild-type FLAG-SERT. As expected from the results of the cellular localization experiments, the serotonin-uptake activity of SERTΔCT was completely abolished (Fig. 3d) . These results suggest that the C-terminal region of SERT is essential for its membrane trafficking, glycosylation, and subsequent functional expression in the plasma membrane.
Effects of overexpression of FLAG-tagged SERT Cterminal region (FLAG-SERT-CT) on SERT function
To further clarify the importance of the SERT Cterminal region in membrane trafficking and glycosylation, we investigated the serotonin uptake activity and glycosylation state of SERT when FLAG-SERT-CT was overexpressed. The indicated amounts of plasmids encoding full-length FLAG-SERT or FLAG-SERT-CT and empty plasmid (total 20 μg) were transfected into COS-7 cells and cultured for 2 days (Fig. 4a) . As shown in Fig. 4a , overexpression of FLAG-SERT-CT dosedependently increased the serotonin-uptake activity of concomitantly expressed FLAG-SERT. The glycosylation index showed maturely glycosylated SERT was also increased by FLAG-SERT-CT overexpression in a dose-dependent manner (Fig. 4: b and c) . Furthermore, we examined the cellular localization of FLAG-SERT-CT by immunostaining with anti-FLAG antibody. As shown in Fig. 4d , FLAG-SERT-CT localized in vesicular-like structures throughout the cytoplasm. The localization of these FLAG-SERT-CT structures overlapped with structures stained with ER-tracker, suggesting that FLAG-SERT-CT accelerates SERT membrane trafficking toward the plasma membrane at the ER.
To exclude the possibility that the FLAG-tagged protein affects the function of SERT and the localization of the SERT C-terminus, we examined the characteristics of HA-tagged SERT-CT (HA-SERT-CT). Overexpression of HA-SERT-CT similarly upregulated the uptake activity of concomitantly expressed FLAG-SERT (Fig. 5a) . Also, HA-SERT-CT co-localized with ERtracker-stained structures (data not shown), suggesting that overexpression of SERT-CT, and not the tag protein, upregulates the activity of SERT.
To elucidate whether overexpression of SERT-CT specifically upregulates SERT function, we investigated the effects of overexpressed-FLAG-SERT-CT on the function of DAT. FLAG-SERT-CT and FLAG-DAT were concomitantly expressed in COS-7 cells. As shown in Fig. 5b , FLAG-SERT-CT also increased DAT uptake activity, suggesting that the overexpressed SERT-CT did not exclusively affect SERT function.
Effects of overexpression of SERT C-terminal subregions [FLAG-SERT-CT (601 -615) and FLAG-SERT-CT (613 -630)] on SERT function
Larsen et al. previously revealed that C-terminal truncation of SERT (amino acids 614 -630) completely abolished the SERT uptake activity (31) . In addition, truncation of amino acids 615 -630 significantly reduces the SERT uptake activity, whereas the SERT truncation of amino acids 616 -630 did not affect the activity. These results suggest that the region around the proline residue at 614 (Pro-614) would be critical in the functional regulation of SERT. Therefore, we made two types of plasmid that can overexpress SERT C-terminal subregions [FLAG-SERT-CT (601 -615) and FLAG-SERT-CT (613 -630)] in order to clarify which region is responsible for the incremental effects of FLAG-SERT-CT on the SERT uptake activity.
As shown in Fig. 6B , FLAG-SERT-CT (601 -615) increased the uptake activity of concomitantly-expressed FLAG-SERT, whereas FLAG-SERT-CT (613 -630) did not. In addition, FLAG-SERT-CT (613 -630) significantly reduced the SERT uptake activity. These results suggest that the SERT C-terminal subregion corresponding to amino acids 601 -615 is critical for the incremental effects of FLAG-SERT-CT on the SERT uptake activity. Immunocytochemical studies showed that both localization of FLAG-SERT-CT (601 -615) and FLAG-SERT-CT (613 -630) were very similar to that of FLAG-SERT-CT (data not shown).
Effects of proteasome inhibitors as ER stress inducers on SERT function
To understand the physiological and clinical significance of SERT regulation via its membrane trafficking and glycosylation, it is important to know how membrane trafficking of SERT is affected by pathological conditions. To address this issue, we focused on ER stress. Various pathological conditions in the brain cause ER stress. Excess calcium ions and reactive oxygen species are produced in the case of ischemia. On the other hand, degradation-resistant proteins are accumulated in the case of neurodegenerative disease. These , and FLAGtagged subregion of SERT C-terminus used in present study. The deletion mutant of SERT lacking the last 15 amino acids (amino acids 616 -630) possesses uptake activity comparable to that of wild-type SERT. The mutant lacking the last 16 amino acids has 74% of the uptake activity seen in the wild-type. Finally, the mutant lacking the last 17 amino acids is deficient in uptake activity. b) Effects of overexpressed SERT subregions on the uptake activity of SERT. Indicated amount of plasmids encoding FLAG-tagged SERT C-terminal subregion, FLAG-SERT, or empty vector were expressed in COS-7 cells, and the uptake activity of concomitantlyexpressed FLAG-SERT was measured. Overexpression of FLAG-SERT-CT (601 -615), but not FLAG-SERT-CT (615 -630), enhanced the activity of FLAG-SERT. In contrast, FLAG-SERT-CT (615 -630) significantly decreased the uptake activity of SERT (*P<0.0001 vs. control, Student's t-test).
situations could induce ER stress and the subsequent accumulation of unfolded proteins. Therefore, in this study, two proteasome inhibitors, ALLN and lactacystin, which can accumulate unfolded proteins in ER, were used as ER-stress inducers.
COS-7 cells transfected with FLAG-SERT were treated with 20 μM ALLN or 20 μM lactacystin for 24 h before the experiment. In Fig. 7a , we compared the cellular localization of FLAG-SERT between nontreated cells (control) and treated cells (ALLN and lactacystin). In control cells, FLAG-SERT was again mainly localized at the plasma membrane, as in Figs. 1b and 2a (Fig. 7a, left) . In contrast, ALLN treatment caused FLAG-SERT to accumulate at perinuclear structures (Fig. 7a, center) . Lactacystin also caused FLAG-SERT to be retained in punctate structures throughout the cytoplasm (Fig. 7a, right) . These structures were frequently stained by ER-tracker (data not shown). In addition, treatment with ALLN robustly reduced the amount of maturely glycosylated SERT (Fig. 7b) . The effects of ALLN and lactacystin on serotonin uptake activity were examined. As shown in Fig. 7, c and d , respectively, ALLN and lactacystin significantly inhibited SERT activity. To confirm that treatment with proteasome inhibitors really induced ER stress under our experimental conditions, we analyzed the expression of the protein Bip, a marker of ER stress. As shown in Fig. 7e , treatment with ALLN or lactacystin apparently enhanced the expression level of Bip. The ALLN-or lactacystin-induced expression of Bip was further enhanced by co-expression of FLAG-SERT (Fig. 7e) . These results suggest that SERT serotonin-uptake Fig. 7 . Effects of ALLN and lactacystin, ER stress inducers, on SERT function. Two types of proteasome inhibitors, ALLN and lactacystin, were used as ER stress inducers. Cells were treated with ALLN and lactacystin for 24 h. a) Subcellular localization of FLAG-SERT after treatment with ALLN (center) and lactacystin (left). ALLN treatment resulted in accumulation of FLAG-SERT at perinuclear structures. Lactacystin also caused FLAG-SERT to be retained in punctate structures throughout the cytoplasm. Bars indicate 10 μm. b) Glycosylation state of FLAG-SERT after treatment with ALLN. ALLN markedly decreased the amount of maturely glycosylated SERT (arrow). c) and d) Effects of ALLN and lactacystin on SERT serotonin-uptake activity. Both ALLN and lactacystin significantly decreased SERT activity (*P<0.0001 vs. control, Student's t-test). e) Immunoblotting of Bip, a marker for ER stress. ALLN or lactacystin treatment apparently increased the expression of Bip. Concomitantlyexpressed FLAG-SERT further augmented the ALLN-or lactacystin-induced expressed of Bip.
activity is attenuated via the inhibition of SERT membrane trafficking in the case of pathological states that evoke ER stress.
Discussion
The aim of this study was to clarify the mechanisms underlying SERT functional regulation via its membrane trafficking and glycosylation. At first, we investigated whether chemicals that inhibit membrane trafficking between the ER and the plasma membrane via the Golgi apparatus affect SERT function. For this purpose, we used two types of drugs, BFA and IQ (40, 42) , each of which inhibits membrane trafficking from the ER to the Golgi apparatus in a different manner. As shown in Fig. 1 , both drugs caused SERT to be retained in the ER and reduced the expression of functional SERT at the plasma membrane, thereby attenuating its serotonin uptake activity. These results suggest that SERT membrane trafficking to the plasma membrane plays an important role in the regulation of SERT serotoninuptake activity.
We next attempted to elucidate the molecular mechanisms underlying membrane trafficking and glycosylation of SERT. To address this issue, we focused on the C-terminal region of SERT because this region is suggested to be critical in functional expression of DAT and NET, other members of the monoaminetransporter family (32 -34) . Moreover, Larsen et al. recently reported that the C-terminal 17 amino acids are essential for cell-surface expression of human SERT (31) . It is also reported that the trafficking of SERT to the presynaptic terminal is absent in knock-in mice expressing C-terminus-truncated SERT (47) . Consistent with these previous findings, mutant rat SERT in which the C-terminal 30 amino acids were deleted (SERT-ΔCT), was lacking in serotonin uptake activity and glycosylation modification (Figs. 2 and 3 ). Furthermore, in immunocytochemical studies, SERTΔCT mainly existed in the ER and, not at the plasma membrane (Fig. 2) . These results again confirm that the C-terminus is critical in membrane trafficking, glycosylation, and subsequent functional expression of SERT, in the case of rat SERT as well as human and mouse SERT.
To further elucidate the role of the C-terminal region of SERT in its functional regulation, we investigated the effects of overexpressed SERT C-terminus on the function of full-length SERT. Studies on co-expression of full-length SERT (FLAG-SERT) with C-terminus SERT (FLAG-SERT-CT) revealed that the uptake activity of FLAG-SERT was augmented by FLAG-SERT-CT (Fig. 4) . In addition, maturely glycosylated FLAG-SERT was increased by overexpression of FLAG-SERT-CT (Fig. 4) . Immunocytochemical studies suggest that FLAG-SERT-CT exerted these effects on FLAG-SERT at the ER, probably by enhancing membrane trafficking of SERT to the Golgi apparatus (Fig. 4) .
The C-terminal region of SERT has been reported to be important for anchoring SERT to the actin cytoskeleton lining the plasma membrane, via actin binding proteins such as MacMARCKS (21) . In our previous study, GFP-tagged SERT C-terminus (GFP-SERT-CT) was mainly localized to the plasma membrane, cytosol, and nucleus, but not in the ER, when it was overexpressed in COS-7 cells (30) although FLAG-tagged SERT C-terminus or FLAG-tagged subregion of SERT C-terminus was faintly localized to the plasma membrane (data not shown). The serotonin-uptake activity of SERT, concomitantly expressed with GFP-SERT-CT, was attenuated, probably because excess GFP-SERT-CT interfered with the interaction of SERT with the actin cytoskeleton. Therefore, we speculated that overexpressed GFP-SERT-CT functions as a molecular decoy that disturbs proper anchoring of SERT to the plasma membrane. However, these previous findings conflict with our present data. One speculation that might resolve this discrepancy is the difference in protein tags used in these studies. In our previous study, we used GFP as a tag fused with the SERT C-terminus (SERT-CT). Because the molecular size of GFP (approximately 32 kDa) is considerably larger than that of SERT-CT (amino acid 30), cellular localization of GFP-SERT-CT was likely influenced by GFP, rather than SERT-CT. However, in this present study, FLAG or HA was used as a protein tag to fuse with SERT-CT. As FLAG (amino acid 9) and HA (amino acid 13) are protein tags with small molecular size, the localization of FLAG-SERT-CT or HA-SERT-CT likely reflected the localization of SERT-CT itself.
As shown in Fig. 5b , overexpression of FLAG-SERT-CT also enhanced dopamine uptake activity of DAT. This result suggests that incremental effects of FLAG-SERT-CT on transporter activity are not specific to SERT alone. Because the homology of amino acids between SERT and DAT is relatively high, approximately 60%, the property of SERT-CT shown in this study may be conserved among the monoamine-transporter family, which includes SERT, DAT, and NET. Miranda et al. reported that Gly-585, Lys-590, and Asp-600 of DAT C-terminus were important for its export from the ER (48) . In the C-terminus of SERT and NET, Gly and Lys, but not Asp, are conserved, suggesting the similarity of mechanism underlying the membrane trafficking of monoamine transporters. This could explain the reason why SERT-C terminus up-regulated the DAT function. ER stress is caused by various factors, such as peroxidative stress and the accumulation of unfolded proteins, in pathological states including brain ischemia, neurodegeneration, and aging. In this study, we investigated the effects of proteasome inhibitors as inducers of ER stress on the functional regulation of SERT to clarify the physiological and pathological significance of SERT regulation via its membrane trafficking. Both ALLN and lactacystin, proteasome inhibitors, induced ER stress, inhibited trafficking to plasma membrane and glycosylation of SERT, and attenuated the serotoninuptake activity of SERT (Fig. 7) . ALLN-or lactacystininduced ER stress was further enhanced by co-expression of SERT (Fig. 7e) , suggesting that SERT is also an accelerator of ER stress when it was poorly folded and retained at the ER. These findings indicate that SERT serotonin-uptake activity is decreased via inhibition of its membrane trafficking when pathological states induce ER stress. Because SERT is thought to be involved in the pathology of mood disorder and anxiety disorder, these results might contribute to our understanding of the pathophysiology of depression and anxiety after the insult of brain ischemia, neurodegeneration, mental stress, and aging.
In our present study, it is interesting that overexpression of SERT-CT induced an increase in the serotonin uptake activity and membrane trafficking of coexpressed SERT. If the SERT C-terminus is essential for the interaction of SERT with some factors that are involved in SERT membrane trafficking, overexpression of SERT-CT would disturb this interaction, thereby exerting dominant negative effects on SERT membrane trafficking. If this were the case, then the serotoninuptake activity of SERT would be reduced. We speculate on two reasons why SERT-CT unexpectedly enhanced membrane trafficking and the functional expression of SERT. These two reasons could also explain the reason why the SERTΔCT was retained in the ER.
First, it is possible that overexpressed SERT-CT masks the ER retention signal of SERT, thereby facilitating SERT membrane trafficking from the ER to the Golgi apparatus. An ER retention signal, such as the KLDL signal, disturbs trafficking of molecules toward the Golgi apparatus and also accelerates retrograde trafficking from the Golgi apparatus to the ER, thereby allowing the molecule to be retained in the ER. In a variety of proteins, the masking of ER retention signals by intramolecular domains triggers trafficking to the Golgi (49 -52) . It is predicted that there are sequences like ER retention signals, KRRER, in the fourth intracellular loop of human SERT (31) . Therefore, if the C-terminus of SERT masks this retention signal, exogenously overexpressed SERT-CT might accelerate the masking of the ER retention signal and subsequent trafficking of SERT to the Golgi apparatus.
If this is the case, the overexpression of SERT-CT could restore the trafficking of SERTΔCT to the plasma membrane. However, SERT-CT could not restore the serotonin uptake activity of concomitantly-expressed SERTΔCT (data not shown), suggesting that this hypothesis is not plausible for explaining the present results.
Alternatively, it is possible that the ER export signal in SERT-CT directly mediates the facilitation of trafficking from the ER to the Golgi apparatus. ER export signals, which exist in various membrane proteins, facilitate trafficking of proteins synthesized in the ER to the Golgi apparatus by accelerating budding of vesicles from the ER (53) . This hypothesis can clearly explain the reason why the SERTΔCT was retained at the ER. Recently, two motifs, Di-acidic motif and Dihydrophobic motif, were proposed as ER export signals (53) . In the case of the SERT C-terminus, there are three putative Di-hydrophobic motifs (underlined sequences as follows: PGTLKERIIKSITPETPTRIPCGDIRMNAV) and no Di-acidic motifs. If these putative sequences function as ER export signals, exogenously overexpressed SERT-CT might directly accelerate the budding of vesicles containing SERT via an unknown mechanism by which ER export signals in SERT-CT synergistically function with those in concomitantlyexpressed SERT.
Based on the studies using subregions of the SERT Cterminus, the region proximal to membrane (amino acids 601 -615), but not the region distal to membrane (amino acids 613 -630), is responsible for the incremental effects of SERT-CT on the uptake activity of concomitantly-expressed SERT. According to the previous studies using deletion mutants of SERT C-terminus (31), the region around Pro-614 was important for SERT membrane trafficking as mentioned in the results. In addition, according to the studies on DAT C-terminus as mentioned above (48), Gly-602 and Lys-610 is predicted to be important for ER export. As all of these three residues are contained in the proximal region, the overexpression of this region might affect the membrane trafficking of concomitantly-expressed SERT. In contrast to the proximal region, overexpression of the region distal to membrane (amino acids 613 -630) significantly reduced the SERT uptake activity. Although we do not have evidence that can explain the mechanism, the distal region might be important for the interaction of SERT with other regulatory proteins. Overexpression of this region would function as a molecular decoy that disturbs the proper protein-protein interaction of SERT.
In the present study, SERT-CT and its subregions were mainly expressed in ER, although these were faintly localized in the plasma membrane (data not shown). To the contrary, the hypothesis that ER export signal exists in SERT-CT is contradictory to the finding that SERT-CT itself is still localized at the ER. It is possible that SERT-CT would be readily trafficked to the Golgi apparatus if the ER export signals in SERT-CT function. From the present findings, we cannot fully understand the role of SERT C-terminus in membrane trafficking in view of ER retention and/or export signals. Further studies are necessary to clarify the ER retention and export signals of SERT, which control its membrane trafficking from the ER to the Golgi apparatus.
In conclusion, our present study demonstrates that membrane trafficking of SERT between the ER and the plasma membrane via the Golgi apparatus is important for the functional regulation of SERT. The C-terminus of SERT is a potential therapeutic target, and drugs targeting this region may be able to alter SERT function via regulation of its membrane trafficking.
